+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Alpha-1A Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha-1A Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Vasopressin V1 Receptor (V1R) Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Vasopressin V1 Receptor (V1R) Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Serotonin Transporter Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Serotonin Transporter Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Glutamate Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Glutamate Receptor Antagonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Heat Shock Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Heat Shock Protein Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Sclerostin Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Sclerostin Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
D1 Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

D1 Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
D Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

D Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Neurokinin (NK) Receptor Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Neurokinin (NK) Receptor Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Vascular Endothelial Growth Factor Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Vascular Endothelial Growth Factor Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Orexin Receptor (Hypocretin Receptor) Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Orexin Receptor (Hypocretin Receptor) Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Non-Structural Protein 5 Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Non-Structural Protein 5 Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Androgen Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Androgen Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Bcl-xL Protein Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Bcl-xL Protein Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Growth Hormone Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Growth Hormone Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Alpha-2 Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Alpha-2 Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Aldose Reductase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Aldose Reductase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more